Half-Life as a Therapeutic Design Axis: Targeting Short-Lived lncRNAs With Antisense Oligonucleotides
{{output}}
Engineering RNA stability has become a cornerstone of modern therapeutics, almost entirely in one direction: mRNA vaccines established stabilisation of exogenous transcripts as a powerful design axis. The symmetric operation-exploitation of instability in endo... ...
